Related Experiment Videos
Cardiovascular syndromes X, endothelial dysfunction and insulin resistance
J Goodfellow1, D Owens, A Henderson
1Department of Cardiology, University of Wales College of Medicine, Cardiff, UK.
Diabetes Research and Clinical Practice
|July 1, 1996
Summary
Cardiac Syndrome X, also known as microvascular angina, shares key characteristics with metabolic Syndrome X, including insulin resistance and endothelial dysfunction. These findings suggest a deeper connection between these two conditions.
Area of Science:
- Cardiology
- Metabolic Health
- Endocrinology
Background:
- Cardiac Syndrome X (microvascular angina) is a clinical condition.
- Metabolic Syndrome X describes an association between insulin resistance, dyslipidaemia, hypertension, and atheroma.
- The shared name 'Syndrome X' suggests a potential underlying link.
Purpose of the Study:
- To explore the potential commonalities between Cardiac Syndrome X and metabolic Syndrome X.
- To investigate the role of insulin resistance and endothelial dysfunction in microvascular angina.
Main Methods:
- Review of existing evidence linking microvascular angina to metabolic factors.
- Analysis of studies examining insulin resistance and endothelial dysfunction in Cardiac Syndrome X.
Main Results:
- Evidence suggests microvascular angina is characterized by insulin resistance.
- Endothelial dysfunction is also implicated in Cardiac Syndrome X.
- These findings align with characteristics of metabolic Syndrome X.
Conclusions:
- Cardiac Syndrome X and metabolic Syndrome X may share underlying pathophysiological mechanisms, particularly insulin resistance and endothelial dysfunction.
- The implications of these shared mechanisms warrant further investigation and discussion.